IL35658A - 2, 6 - Diamino - 9 -) B - D - Arbinopuranosil (- Purine, its preparation and use in pharmacy - Google Patents

2, 6 - Diamino - 9 -) B - D - Arbinopuranosil (- Purine, its preparation and use in pharmacy

Info

Publication number
IL35658A
IL35658A IL35658A IL3565870A IL35658A IL 35658 A IL35658 A IL 35658A IL 35658 A IL35658 A IL 35658A IL 3565870 A IL3565870 A IL 3565870A IL 35658 A IL35658 A IL 35658A
Authority
IL
Israel
Prior art keywords
compound
formula
animal
preparing
pharmaceutical
Prior art date
Application number
IL35658A
Other languages
English (en)
Hebrew (he)
Other versions
IL35658A0 (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IL35658A0 publication Critical patent/IL35658A0/xx
Publication of IL35658A publication Critical patent/IL35658A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04—Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16—Purine radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
IL35658A 1969-11-17 1970-11-16 2, 6 - Diamino - 9 -) B - D - Arbinopuranosil (- Purine, its preparation and use in pharmacy IL35658A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US87744369A 1969-11-17 1969-11-17

Publications (2)

Publication Number Publication Date
IL35658A0 IL35658A0 (en) 1971-01-28
IL35658A true IL35658A (en) 1974-10-22

Family

ID=25369972

Family Applications (1)

Application Number Title Priority Date Filing Date
IL35658A IL35658A (en) 1969-11-17 1970-11-16 2, 6 - Diamino - 9 -) B - D - Arbinopuranosil (- Purine, its preparation and use in pharmacy

Country Status (26)

Country Link
US (1) US3666856A (fi)
JP (1) JPS5429520B1 (fi)
AT (1) AT309696B (fi)
BE (1) BE759011A (fi)
BR (1) BR6915136D0 (fi)
CA (1) CA967564A (fi)
CH (2) CH555833A (fi)
CS (1) CS181701B2 (fi)
DE (1) DE2056327C2 (fi)
DK (1) DK128117B (fi)
ES (2) ES385590A1 (fi)
FI (1) FI54315C (fi)
FR (1) FR2073364B1 (fi)
GB (2) GB1338905A (fi)
HU (1) HU163812B (fi)
IE (1) IE34737B1 (fi)
IL (1) IL35658A (fi)
LU (1) LU62071A1 (fi)
MC (1) MC869A1 (fi)
NL (1) NL171589C (fi)
NO (1) NO128156B (fi)
PL (1) PL81167B1 (fi)
SE (1) SE385374B (fi)
YU (2) YU35033B (fi)
ZA (1) ZA707722B (fi)
ZM (1) ZM12970A1 (fi)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4081534A (en) * 1973-09-11 1978-03-28 Burroughs Wellcome Co. Amino purine nucleosides as autoimmune suppressant agents
GB1562899A (en) * 1975-06-17 1980-03-19 Wellcome Found Pharmaceutical compositions containing substituted 9-( -d-arabnofuranosyl)purine-5'-phosphate and salts thereof
US4210745A (en) * 1978-01-04 1980-07-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Procedure for the preparation of 9-β-D-arabinofuranosyl-2-fluoroadenine
DE3319282A1 (de) * 1983-05-27 1984-11-29 Gödecke AG, 1000 Berlin Verwendung von adenosin bei der behandlung von herpes
GB8712745D0 (en) * 1987-05-30 1987-07-01 Wellcome Found Antiviral compounds
KR0138996B1 (ko) * 1988-03-16 1998-04-30 레이몬드 에이치. 칸 치환된 아데닌 유도체 및 이를 함유하는 약제학적 조성물
IE882585L (en) * 1988-08-25 1990-02-25 Prendergast Patrick T Viral treatment system
US5292725A (en) * 1988-08-25 1994-03-08 Prendergast Patrick T Administering particular compounds against various parasites, mycoplasmas, other indications and other infections
US5681941A (en) * 1990-01-11 1997-10-28 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US5308837A (en) * 1990-08-22 1994-05-03 Merrell Dow Pharmaceuticals Inc. 5'-amine substituted adenosine analogs as immunosuppressants
US6338963B1 (en) 1994-07-25 2002-01-15 Neotherapeutics, Inc. Use of carbon monoxide dependent guanylyl cyclase modifiers to stimulate neuritogenesis
US6232463B1 (en) 1997-10-09 2001-05-15 Isis Pharmaceuticals, Inc. Substituted purines and oligonucleotide cross-linking
US6303617B1 (en) 1998-05-04 2001-10-16 Neotherapeutics, Inc. Serotonin-like 9-substituted hypoxanthine and methods of use
US6288069B1 (en) 1999-11-16 2001-09-11 Neotherapeutics, Inc. Use of 9-substituted hypoxanthine derivatives to stimulate regeneration of nervous tissue
US6407237B1 (en) 2001-02-21 2002-06-18 Neotherapeutics, Inc. Crystal forms of 9-substituted hypoxanthine derivatives
US6849735B1 (en) * 2000-06-23 2005-02-01 Merck Eprova Ag Methods of synthesis for 9-substituted hypoxanthine derivatives
ES2385931T3 (es) 2000-07-07 2012-08-03 Spectrum Pharmaceuticals, Inc. MÉTODOS PARA EL TRATAMIENTO DE NEUROPATíA PERIFÉRICA INDUCIDA POR UNA ENFERMEDAD Y AFECCIONES RELACIONADAS.
US6759427B2 (en) 2001-04-20 2004-07-06 Spectrum Pharmaceuticals, Inc. Synthesis and methods of use of tetrahydroindolone analogues and derivatives
US20030055249A1 (en) * 2001-07-17 2003-03-20 Fick David B. Synthesis and methods of use of pyrimidine analogues and derivatives
CN105237602B (zh) * 2015-06-25 2018-05-18 新乡学院 一种2-氨基阿糖腺苷的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3208997A (en) * 1962-11-15 1965-09-28 Sankyo Co Process for preparing purine and pyrimidine nucleosides
US3407191A (en) * 1966-08-29 1968-10-22 Lilly Co Eli Adamantoate esters of nucleosides
JPH1097965A (ja) * 1996-09-20 1998-04-14 Sony Corp 生産管理方法

Also Published As

Publication number Publication date
IE34737B1 (en) 1975-08-06
YU280670A (en) 1979-12-31
FI54315B (fi) 1978-07-31
YU35033B (en) 1980-06-30
NO128156B (fi) 1973-10-08
NL7016766A (fi) 1971-05-19
CA967564A (en) 1975-05-13
IL35658A0 (en) 1971-01-28
JPS5429520B1 (fi) 1979-09-25
US3666856A (en) 1972-05-30
ZA707722B (en) 1972-06-28
YU35034B (en) 1980-06-30
ZM12970A1 (en) 1972-07-21
LU62071A1 (fi) 1971-08-12
BE759011A (fr) 1971-05-17
CS181701B2 (en) 1978-03-31
NL171589B (nl) 1982-11-16
BR6915136D0 (pt) 1973-04-19
GB1338906A (en) 1973-11-28
SE385374B (sv) 1976-06-28
FR2073364B1 (fi) 1974-03-22
HU163812B (fi) 1973-10-27
FI54315C (fi) 1978-11-10
IE34737L (en) 1971-05-17
FR2073364A1 (fi) 1971-10-01
ES413787A1 (es) 1976-01-16
GB1338905A (en) 1973-11-28
NL171589C (nl) 1983-04-18
DE2056327C2 (de) 1984-10-11
DE2056327A1 (de) 1971-06-03
MC869A1 (fr) 1971-09-28
AT309696B (de) 1973-08-27
DK128117B (da) 1974-03-04
CH555833A (de) 1974-11-15
ES385590A1 (es) 1973-10-01
PL81167B1 (fi) 1975-08-30
YU201978A (en) 1979-12-31
CH555344A (de) 1974-10-31

Similar Documents

Publication Publication Date Title
IL35658A (en) 2, 6 - Diamino - 9 -) B - D - Arbinopuranosil (- Purine, its preparation and use in pharmacy
US3590029A (en) 2-amino-adenosine derivatives
FI87783B (fi) Foerfarande foer framstaellning av terapeutiskt anvaendbara 2',3'-dideoxinukleosider
EP0181154B1 (en) Galactose-c-6 nitrogen mustard compounds and their uses
US3758684A (en) Treating dna virus infections with amino purine derivatives
JPH10507772A (ja) Ｌ−リボフラノシルヌクレオシド
JPS5910587A (ja) グアニン誘導体
US4071680A (en) 5'-Deoxy-5-fluoropyrimidine nucleosides
US4210638A (en) Antiviral composition and method of treating virus diseases
EP0305117B1 (en) 2',3'-dideoxy-3'-fluorothymidine and related compounds for the treatment of adenovirus infections
US4081534A (en) Amino purine nucleosides as autoimmune suppressant agents
US5071983A (en) Therapeutic nucleosides
US3956277A (en) Purine sugar derivatives
US5441932A (en) Sugar compounds for inhibition of the biosynthesis of sugar chains containing sialic acid
JPH01149797A (ja) プリン誘導体
US4038479A (en) Amino purine derivatives
KR0133075B1 (ko) 소화성 궤양 질환 치료용 치료학적 제제
CA1041494A (en) Anti-viral compounds and their synthesis
US4868157A (en) Dipeptidyl 2-amino-1,2-dideoxy-D-glucose derivatives as host resistance enhancers in AIDS-immunocompromised hosts and methods of use
JPH0267295A (ja) プリン誘導体
KR20020050282A (ko) 베타-디-5-티옥실로스 유도체, 제조방법 및 약학적 용도
EP1383505A2 (en) Inosine compounds and their use for treating or preventing an inflamation or a reperfusion disease
WO1995030683A1 (en) Adenosine derivatives
US5612319A (en) Postexposure prevention of HIV infection or seroconversion
WO1988009332A1 (en) Therapeutic nucleosides